Chris Blakeley

Senior Partner

Email: chris.blakeley@transcrip-partners.com

Chris Blakeley has over 20 years of Drug Development experience within the industry as a pharmaceutical physician, after working in the NHS in internal medicine, anaesthesia and intensive care.

He has worked in diverse roles for Pfizer R&D in the UK and USA and on assignments in Spain, Israel and France. Chris led the Development Teams responsible for the successful registration of Sutent® in renal and GI cancers and Toviaz® in overactive bladder and recently led work on a portfolio of respiratory development projects. Chris graduated in medicine and has an M.D. from the University of Birmingham.